Literature DB >> 16452634

GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction.

C Laura Sayas1, Aafke Ariaens, Bas Ponsioen, Wouter H Moolenaar.   

Abstract

Glycogen synthase kinase-3 (GSK-3) is a multifunctional serine/threonine kinase that is usually inactivated by serine phosphorylation in response to extracellular cues. However, GSK-3 can also be activated by tyrosine phosphorylation, but little is known about the upstream signaling events and tyrosine kinase(s) involved. Here we describe a G protein signaling pathway leading to GSK-3 activation during lysophosphatidic acid (LPA)-induced neurite retraction. Using neuronal cells expressing the LPA(1) receptor, we show that LPA(1) mediates tyrosine phosphorylation and activation of GSK-3 with subsequent phosphorylation of the microtubule-associated protein tau via the G(i)-linked PIP(2) hydrolysis-Ca(2+) mobilization pathway. LPA concomitantly activates the Ca(2+)-dependent tyrosine kinase Pyk2, which is detected in a complex with GSK-3beta. Inactivation or knockdown of Pyk2 inhibits LPA-induced (but not basal) tyrosine phosphorylation of GSK-3 and partially inhibits LPA-induced neurite retraction, similar to what is observed following GSK-3 inhibition. Thus, Pyk2 mediates LPA(1)-induced activation of GSK-3 and subsequent phosphorylation of microtubule-associated proteins. Pyk2-mediated GSK-3 activation is initiated by PIP(2) hydrolysis and may serve to destabilize microtubules during actomyosin-driven neurite retraction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452634      PMCID: PMC1415316          DOI: 10.1091/mbc.e05-07-0688

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  71 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  Activation of a novel calcium-dependent protein-tyrosine kinase. Correlation with c-Jun N-terminal kinase but not mitogen-activated protein kinase activation.

Authors:  H Yu; X Li; G S Marchetto; R Dy; D Hunter; B Calvo; T L Dawson; M Wilm; R J Anderegg; L M Graves; H S Earp
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

3.  Cell biology. GSK-3beta and microtubule assembly in axons.

Authors:  Feng-Quan Zhou; William D Snider
Journal:  Science       Date:  2005-04-08       Impact factor: 47.728

4.  Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts.

Authors:  G I Welsh; J C Patel; C G Proud
Journal:  Anal Biochem       Date:  1997-01-01       Impact factor: 3.365

5.  Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase.

Authors:  M Lesort; R S Jope; G V Johnson
Journal:  J Neurochem       Date:  1999-02       Impact factor: 5.372

6.  A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation.

Authors:  I Dikic; G Tokiwa; S Lev; S A Courtneidge; J Schlessinger
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

7.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.

Authors:  D A Cross; D R Alessi; P Cohen; M Andjelkovich; B A Hemmings
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

8.  Glycogen synthase kinase-3beta phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons.

Authors:  Niraj Trivedi; Phil Marsh; Robert G Goold; Alison Wood-Kaczmar; Phillip R Gordon-Weeks
Journal:  J Cell Sci       Date:  2005-03-01       Impact factor: 5.285

9.  Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation.

Authors:  U Wagner; M Utton; J M Gallo; C C Miller
Journal:  J Cell Sci       Date:  1996-06       Impact factor: 5.285

10.  Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells.

Authors:  M Hirose; T Ishizaki; N Watanabe; M Uehata; O Kranenburg; W H Moolenaar; F Matsumura; M Maekawa; H Bito; S Narumiya
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

View more
  39 in total

1.  Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.

Authors:  Santiago V Salazar; Timothy O Cox; Suho Lee; A Harrison Brody; Annabel S Chyung; Laura T Haas; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2018-12-05       Impact factor: 6.167

Review 2.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 3.  GSK3beta: role in therapeutic landscape and development of modulators.

Authors:  S Phukan; V S Babu; A Kannoji; R Hariharan; V N Balaji
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

4.  Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation.

Authors:  Yuanjie Sun; Nam-Ho Kim; Haijie Yang; Seung-Hyuk Kim; Sung-Oh Huh
Journal:  Mol Cells       Date:  2011-04-14       Impact factor: 5.034

Review 5.  ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases.

Authors:  André Schmandke; Antonio Schmandke; Stephen M Strittmatter
Journal:  Neuroscientist       Date:  2007-10       Impact factor: 7.519

Review 6.  Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia.

Authors:  Michael J Berridge
Journal:  Prion       Date:  2012-08-16       Impact factor: 3.931

7.  Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss.

Authors:  Suho Lee; Santiago V Salazar; Timothy O Cox; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

8.  Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice.

Authors:  Alan P Kozikowski; Hendra Gunosewoyo; Songpo Guo; Irina N Gaisina; Richard L Walter; Ariel Ketcherside; Colleen A McClung; Andrew D Mesecar; Barbara Caldarone
Journal:  ChemMedChem       Date:  2011-07-05       Impact factor: 3.466

9.  Adrenergic signaling regulates mitochondrial Ca2+ uptake through Pyk2-dependent tyrosine phosphorylation of the mitochondrial Ca2+ uniporter.

Authors:  Jin O-Uchi; Bong Sook Jhun; Shangcheng Xu; Stephen Hurst; Anna Raffaello; Xiaoyun Liu; Bing Yi; Huiliang Zhang; Polina Gross; Jyotsna Mishra; Alina Ainbinder; Sarah Kettlewell; Godfrey L Smith; Robert T Dirksen; Wang Wang; Rosario Rizzuto; Shey-Shing Sheu
Journal:  Antioxid Redox Signal       Date:  2014-06-25       Impact factor: 8.401

10.  Human neural progenitors express functional lysophospholipid receptors that regulate cell growth and morphology.

Authors:  Jillian H Hurst; Jennifer Mumaw; David W Machacek; Carla Sturkie; Phillip Callihan; Steve L Stice; Shelley B Hooks
Journal:  BMC Neurosci       Date:  2008-12-11       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.